DrCaitrin Rowe
AST PROF
PH-PHARMTHERAPY TRNSL RSCH
GRANTS
- GRANTPrecision Medicine for All of Us Researchers Collective medicina de Precision: Colectivo de Investigadores Salud para TodosNational Institute of Health Od8 May 2025 - 31 Aug 2025
- GRANTPharmacogenomics validation studiesOhio Attorney General21 Apr 2025 - 31 Oct 2026
- GRANTCardiovascular Adverse Events Related to Aromatase Inhibitors in Breast CancerFlorida Breast Cancer Foundation18 Jul 2024 - 30 Jun 2026
- GRANTDevelopment of Integrated Precision Medicine Models in Adults with Cardiovascular DiseaseNational Institute of Health Nhlbi10 Jul 2024 - 31 Jul 2027
- GRANTCardiovascular Adverse Events Related to Aromatase Inhibitors in Female Breast CancerNational Institute of Health1 Mar 2024 - 31 Aug 2024
- GRANTHypertension Prediction and Identification in All of UsNational Institute of Health Nhlbi7 Sep 2023 - 30 Nov 2025
- GRANTPreemptive pharmacogenetic testing in medically underserved populationsNational Institute of Health Nhgri1 Sep 2021 - 31 Jan 2027
- GRANTReplication of GenHAT GWAS signals in Pharmacogenomic Evaluation of Antihypertensive Responses (PEAR) and Genetic Epidemiology of Responses to Antihypertensives (GERA)National Institute of Health6 Aug 2021 - 31 Aug 2021
- GRANTUsing Artificial Intelligence to Identify Patients Most Likely to Benefit from Preemptive Pharmacogenetic TestingUF Health Shands Hospital16 Jul 2021 - 30 Jun 2024
- GRANTUse of Real-World Evidence to Characterize Patients with Uncontrolled HypertensionMedical Device Innovation Consortium20 Sep 2020 - 31 Mar 2021
- GRANTPrecision antiplatelet therapy after percutaneous coronary interventionNational Institute of Health Nhlbi15 Jun 2020 - 30 Jun 2026
- GRANTINTEGRATIVE DATA APPROCACHES FOR RESISTANT HYPERTENSION IDENTIFICATION AND PREDICTIONNational Institute of Health Nhlbi25 May 2018 - 30 Jun 2022